Department of Medical and Clinical Genetics, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland; Applied Tumor Genomics, Research Programs Unit, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland; Finnish Cancer Registry, Helsinki, Helsinki, Finland.
Finnish Cancer Registry, Helsinki, Helsinki, Finland.
Acta Oncol. 2024 Nov 4;63:841-849. doi: 10.2340/1651-226X.2024.40757.
Many non-neoplastic diseases have been established to be tumorigenic, and cancers are sometimes misdiagnosed as non-neoplastic diseases. We conducted a comprehensive registry-based study of site-specific cancer diagnosis risk following the diagnosis of any preceding medical condition (PMC) encoded by the International Classification of Diseases (ICD)-10 classification.
We analyzed healthcare data and cancer data for a random population-based sample of 2.5 million individuals living in Finland on January 1, 2000. Hazard ratios for each PMC and cancer pair were estimated using piecewise constant hazard regression models. P-values were corrected for multiple testing with the Bonferroni method.
Several lifestyle-related PMCs were associated with the risk of cancer diagnosis, exemplified by chronic obstructive pulmonary disease and subsequent lung cancer diagnosis risk (female hazard ratio [HR] = 9.91, 95% confidence interval [CI]: 9.18-19.7, p-adj. < 0.0001; male HR = 5.69, 95% CI: 5.43-5.96, p-adj. < 0.0001). Diagnosis risk of ill-defined cancers appeared to increase following diagnosis of Alzheimer's disease (AD). We identified rare PMCs of potential interest.
A considerable proportion of the statistically significant associations were explainable by tobacco smoking and alcohol use. The enrichment of ill-defined cancer diagnoses in persons with AD, together with the overall inverse association between AD and cancer, may reflect underdiagnosis of cancer in this patient population. Our results provide a useful resource for research on the prevention and early detection of cancer.
许多非肿瘤性疾病已被证实具有致癌性,而癌症有时也会被误诊为非肿瘤性疾病。我们对国际疾病分类第十版(ICD-10)编码的任何先前医疗条件(PMC)诊断后特定部位癌症诊断风险进行了一项基于综合登记的研究。
我们分析了芬兰 250 万随机人群的医疗保健数据和癌症数据,这些人于 2000 年 1 月 1 日居住在芬兰。使用分段常数风险回归模型估计了每个 PMC 和癌症对的风险比。使用 Bonferroni 方法校正了多重检验的 P 值。
几种与生活方式相关的 PMC 与癌症诊断风险相关,例如慢性阻塞性肺疾病和随后的肺癌诊断风险(女性风险比 [HR] = 9.91,95%置信区间 [CI]:9.18-19.7,p 调整 < 0.0001;男性 HR = 5.69,95% CI:5.43-5.96,p 调整 < 0.0001)。阿尔茨海默病(AD)诊断后,未明确诊断癌症的诊断风险似乎增加了。我们发现了一些潜在有趣的罕见 PMC。
很大一部分具有统计学意义的关联可以用吸烟和饮酒来解释。AD 患者中未明确诊断癌症的诊断增多,以及 AD 与癌症之间的总体负相关,可能反映了该患者人群中癌症的漏诊。我们的研究结果为癌症的预防和早期发现研究提供了有用的资源。